Belfius Bank
Belfius Bank is a banking institution based in Brussels, Belgium, established in 1996 to serve the financial needs of local authorities and the broader community. The bank focuses on collecting savings deposits and investments through its distribution networks across Belgium. It reinvests these funds into society by providing loans to individuals, self-employed individuals, small and medium-sized enterprises, as well as corporate, public, and social institutions. With a diverse range of services, Belfius Bank also engages in sectors such as insurance and life sciences. The governance and management of the bank's assets are overseen by its Board of Directors, ensuring responsible stewardship and alignment with community interests.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Belgium
Hoplr
Venture Round in 2023
Founded in Belgium in 2014 by Jennick Scheerlinck and Jonas Heirwegh, Hoplr is a social network that connects neighbors online and facilitates offline meetings. Its mission is to foster social cohesion, inclusion, and citizen participation by harnessing collective resources such as time, knowledge, volunteers, and infrastructure.
Hoplr
Series A in 2021
Founded in Belgium in 2014 by Jennick Scheerlinck and Jonas Heirwegh, Hoplr is a social network that connects neighbors online and facilitates offline meetings. Its mission is to foster social cohesion, inclusion, and citizen participation by harnessing collective resources such as time, knowledge, volunteers, and infrastructure.
Hoplr
Series A in 2019
Founded in Belgium in 2014 by Jennick Scheerlinck and Jonas Heirwegh, Hoplr is a social network that connects neighbors online and facilitates offline meetings. Its mission is to foster social cohesion, inclusion, and citizen participation by harnessing collective resources such as time, knowledge, volunteers, and infrastructure.
ImCyse
Debt Financing in 2019
Imcyse SA is a clinical-stage biopharmaceutical company based in Liège, Belgium, specializing in innovative immunotherapeutic solutions aimed at treating severe chronic autoimmune diseases. Founded in 2010, Imcyse is pioneering a unique technology platform that employs Imotopes™, specifically modified peptides that target immune cells responsible for organ damage. This approach facilitates the generation of cytolytic CD4 T-cells, which selectively eliminate antigen-presenting cells and autoantigen-specific lymphocytes, thereby addressing diseases with limited treatment options. The company has shown proof of concept across various indications and has completed its initial clinical trial for type 1 diabetes, yielding promising outcomes. In addition to type 1 diabetes, Imcyse is actively developing a pipeline of therapies for multiple autoimmune diseases, aiming to provide effective treatment while preserving overall immune defense.
Hoplr
Series A in 2018
Founded in Belgium in 2014 by Jennick Scheerlinck and Jonas Heirwegh, Hoplr is a social network that connects neighbors online and facilitates offline meetings. Its mission is to foster social cohesion, inclusion, and citizen participation by harnessing collective resources such as time, knowledge, volunteers, and infrastructure.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.